The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism.

Carlo Alfieri, Anna Regalia, Francesca Zanoni, Simone Vettoretti, Mario Cozzolino, Piergiorgio Messa

Journal: Blood purification 2019;47(1-3):37-44

PMID: 30223271

Full Text on S. Karger AG, Basel, Switzerland View on PubMed

Abstract

Secondary hyperparathyroidism (SHPT) is a frequent condition in the presence of chronic kidney disease (CKD). In CKD patients, SHPT is reported to increase both morbidity and mortality, especially cardiovascular. The difficulty in the treatment of SHPT in clinical practice is frequently encountered from a not always adequate conduct of the clinicians and a common non-compliance to the therapy of CKD patients. In this review, the greatest difficulties from clinicians and CKD-patients' point of view in the treatment of SHPT will be addressed, with particular attention to those related to dialysis features, nutritional habits, and medical therapy.

Address: Department of Medicine, Unit of Nephrology, Dialysis and Renal Transplant, Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico di Milano, Milan, [email protected].; Department of Medicine, Unit of Nephrology, Dialysis and Renal Transplant, Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico di Milano, Milan, Italy.; Department of Health Sciences, Renal Division, San Paolo Hospital, University of Milan, Milan, Italy.; Department of Medicine, Unit of Nephrology, Dialysis and Renal Transplant, Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico di Milano, Milan, Italy.; Università Degli Studi Di Milano, Milan, Italy.

DOI: 10.1159/000492918

Link outs

Free resources

Medical:

https://medlineplus.gov/chronickidneydisease.html

Other Literature Sources:

https://scite.ai/reports/30223271

Subscription / membership required

Full Text Sources:

https://doi.org/10.1159/000492918

MeSH Terms: Humans, Hyperparathyroidism, Secondary, Renal Insufficiency, Chronic, Treatment Adherence and Compliance